| Website | kbcpe.be/en |
| Phone | +32 (0)2 429 36 45 |
| Employees | |
| Description | Private Equity |
KBC Private Equity - the investment company of KBC Group - provides development capital and finances buy-outs to medium-sized companies in Belgium and in Central and Eastern Europe, KBC’s home markets. Boasting an experienced team of 28 people, it has more than 60 active investments in portfolio with a market value in excess of EUR 400 million.
KBC Private Equity aims to become one of the leading private equity providers on KBC Group’s home markets. As an active shareholder with a long-term perspective, KBC Private Equity is involved in taking strategic decisions and providing support to management teams.
| Company | Date | Round | Size | Participants |
| Biocartis | 4/10 | Series B | $41.3M | 5 |
| arGEN-X | 2/10 | Series A | $4.5M | 7 |
| Metabolex | 11/09 | Unattributed | $8.6M | 12 |
| arGEN-X | 9/09 | Series A | $13.6M | 4 |
| Pronota | 6/09 | Series B | $7.36M | 7 |
| Aristo Music | 11/08 | Unattributed | $3.38M | 4 |
| Metabolex | 4/07 | Series D | $32M | 16 |
| Movetis | 1/07 | Series A | €49M | 7 |
| Pronota | 8/06 | Series A | $10.6M | 4 |
